$AQB

AQUABOUNTY TECHNOLOGIES INC

CIK:0001603978|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Costs and expenses
Sales and marketing				$ 6,613
General and administrative	$ 799,258	$ 1,196,841	$ 1,420,824	2,355,908
Total costs and expenses	799,258	1,196,841	1,420,824	2,362,521
Operating loss	(799,258)	(1,196,841)	(1,420,824)	(2,362,521)
Other (expense) income
Interest expense	(529,491)		(829,476)
Loan forgiveness				2,008,046
Other expense, net	(3,716)	(2,979)	(6,966)	(7,413)
Total other (expense) income	(533,207)	(2,979)	(836,442)	2,000,633
Loss from continuing operations	(1,332,465)	(1,199,820)	(2,257,266)	(361,888)
Loss from discontinued operations	(298,502)	(2,173,217)	(573,771)	(2,610,014)
Net loss	(1,630,967)	(3,373,037)	(2,831,037)	(2,971,902)
Other comprehensive income
Foreign currency translation gain				688,229
Comprehensive loss	$ (1,630,967)	$ (3,373,037)	$ (2,831,037)	$ (2,283,673)
Basic and diluted net loss per share
Net loss from continuing operation, per share, basic	$ (0.26)	$ (0.31)	$ (0.46)	$ (0.10)
Net loss from continuing operation, per share, diluted	(0.26)	(0.31)	(0.46)	(0.10)
Net loss from discontinued operation, per share, basic	(0.06)	(0.56)	(0.12)	(0.67)
Net loss from discontinued operation, per share, diluted	(0.06)	(0.56)	(0.12)	(0.67)
Total basic net (loss) income per share	(0.32)	(0.87)	(0.58)	(0.77)
Total diluted net (loss) income per share	$ (0.32)	$ (0.87)	$ (0.58)	$ (0.77)
Weighted average number of common shares -
Weighted average number of shares outstanding, basic	5,147,204	3,872,587	4,858,210	3,869,708
Weighted average number of shares outstanding, diluted	5,147,204	3,872,587	4,858,210	3,869,708

Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities
Net loss	$ (2,831,037)	$ (2,971,902)
Adjustment to reconcile net loss to net cash used in operating activities:
Share-based compensation	5,014	56,888
Long-lived asset impairment		1,218,866
Loan forgiveness		(2,008,046)
Other non-cash expense	513,859
Changes in operating assets and liabilities:
Prepaid expenses and other assets	22,660	(501,960)
Accounts payable and accrued liabilities	(83,637)	308,580
Accrued employee compensation	27,613	(12,473)
Net cash used in operating activities	(2,345,528)	(3,910,047)
Investing activities
Proceeds from asset sales		4,632,679
Net cash provided by investing activities		4,632,679
Financing activities
Repayment of term debt		(232,194)
Proceeds from issuance of common stock and warrants, net	959,550
Proceeds from issuance of preferred stock, net	2,773,974
Net cash provided by (used in) financing activities	3,733,524	(232,194)
Effect of exchange rate changes on cash and cash equivalents		8,769
Net change in cash	1,387,996	499,207
Cash at beginning of period	501,295	230,362
Cash at end of period	1,889,291	729,569
Supplemental disclosure of cash flow information and non-cash transactions:
Interest paid in cash from discontinued operations	293,021	16,903
Non-cash conversion of notes and accrued interest to preferred stock	$ 4,315,616
Non-cash conversion of accounts payable to current debt		$ 1,847,602

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash	$ 1,889,291	$ 501,295
Prepaid expenses and other current assets	208,661	266,862
Current assets held for sale	9,603,157	9,552,454
Total current assets	11,701,109	10,320,611
Right of use assets, net	7,820	22,982
Total assets	11,708,929	10,343,593
Current liabilities:
Accounts payable and accrued liabilities	523,782	337,038
Accrued employee compensation	939,716	912,103
Other current liabilities	7,820	22,982
Current liabilities held for sale	1,277,934	7,476,254
Total current liabilities	2,749,252	8,748,377
Non-current liabilities held for sale	6,148,134
Long-term debt		3,486,141
Total liabilities	8,897,386	12,234,518
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit):
Preferred stock, $0.01 par value, 5,000,000 shares authorized; 372,976 and nil shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	3,730
Common stock, $0.001 par value, 75,000,000 shares authorized; 5,147,204 and 3,877,695 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	5,147	3,878
Additional paid-in capital	393,896,728	386,368,222
Accumulated deficit	(391,094,062)	(388,263,025)
Total stockholders’ equity (deficit)	2,811,543	(1,890,925)
Total liabilities and stockholders’ equity (deficit)	$ 11,708,929	$ 10,343,593